Status:
COMPLETED
Spatial and Dynamic Characterization of Brain Activity for Language and Posture (Verticality) During Normal Aging. Magnetoencephalography (MEG) Study (MEG-AGING)
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Commissariat A L'energie Atomique
Laboratoire de Psychologie et NeuroCognition
Conditions:
Healthy Volunteers
Eligibility:
All Genders
25-85 years
Phase:
NA
Brief Summary
Depending on the point of view, different definitions of aging have been proposed. Thus, at the biological level, aging corresponds to a natural physiological process that leads to the progressive deg...
Detailed Description
From a cognitive point of view, although healthy older people become slower to analyze information, they remain just as accurate as young adults in performing different cognitive tasks. This necessari...
Eligibility Criteria
Inclusion
- Healthy volunteers from 25 to 85 years old : young group (25-49 years) / aged group (50 to 85 years)
- Right-handed
- Signed informed consent
- French mother tongue
- Speaking fluent French
- Normal or corrected view
- Medical examination conducted prior to participation in the trial
- Registered in the French social security scheme
Exclusion
- Contraindication to Magnetoencephalography (MEG) and/or Magnetic resonance imaging (MRI) : implanted material, claustrophobia,…
- Generally severe condition: cardiac, respiratory, hematological, kidney, liver, cancer
- Regular use of anxiolytics, sedatives, antidepressants, neuroleptics
- Psychiatric pathology characterized
- Alcohol ingestion before the exam
- All categories of protected persons (Pregnant or lactating women, persons subject to a legal protection measure, persons deprived of their liberty by judicial or administrative decision)
- Alcohol ingestion before the exam
- Participation in other ongoing clinical trial with exclusion period or in the previous week
- Score MINI MENTAL STATE EXAMINATION (MMSE) \< 24
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2021
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04036162
Start Date
October 1 2019
End Date
June 22 2021
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUGA
Grenoble, France, 38000